X
Search
X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

Prostate Cancer News

This page features general updates about prostate cancer, research and studies, hot topics, news articles and editorials. You also might be interested in ZERO’s Blog, which features inspiring stories, commentary, and insight into news and current events from contributors throughout the prostate cancer community.

Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years

The New York Times /
For the first time, researchers have results from two independent clinical trials showing that two different drugs help men with nonmetastatic castration-resistant prostate cancer - giving them about two more years before their cancer metastasizes ...

FDA Approves J&J Prostate Cancer Treatment

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson’s Erleada for use in prostate cancer patients whose disease has not spread but continues to grow despite hormone therapy. Read more ...

Low-Carb Diet Tested As Way to Slow Recurrent Prostate Cancer

Findings from a small randomized phase 2 trial showed that overweight men with recurrent prostate cancer (PCa) who adhered to an extremely low-carbohydrate diet for 6 months experienced dramatic weight loss compared with those who ...

Noninvasive Blood Test Enables Early Detection of Prostate Cancer, Study...

A new, noninvasive blood test can reliably detect prostate cancer in patients with inconclusive PSA tests, the test’s developer, CellMax Life, recently announced. Read more ...

Early Prostate Cancer Salvage ADT Therapy Better

Among men who experience biochemical recurrence of prostate cancer (PCa) following radiation therapy, early initiation of salvage androgen-deprivation therapy (ADT) for those with a long PSA doubling time may decrease the risk of cancer-specific mortality, ...

Adverse Prostate Cancer Pathology Accurately Predicted With MRI

Multiparametric magnetic resonance imaging (MP-MRI) can accurately predict adverse pathologic features at the time of radical prostatectomy (RP) for localized prostate cancer, data presented at the 2018 Genitourinary Cancers Symposium suggest. Read more ...

Longer Endocrine Tx Better in Prostate Cancer

Longer-duration androgen deprivation therapy (ADT) prevailed once again over briefer ADT for patients with high-risk nonmetastatic prostate cancer, whereas adding a bisphosphonate did not help, final results of a large randomized trial showed. Read more ...

Loading...

August 2016

July 2016

June 2016